Neupro and Breastfeeding
Although it is unknown if Neupro (rotigotine) passes through human breast milk, it is known to pass through breast milk in rats. Because each woman's situation is different, talk to your healthcare provider about the potential risks and benefits of using Neupro while breastfeeding. Due to the potentially serious side effects of this drug, the manufacturer recommends women use this drug with caution while nursing.
Can Breastfeeding Women Use Neupro?Neupro® (rotigotine) is a medication prescribed to treat Parkinson's disease and restless legs syndrome (RLS) in adults. It is not clear if Neupro passes through breast milk in humans or if it is safe for use while breastfeeding.
Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Neupro recommends the drug be used with caution in nursing women. Therefore, if you are nursing or plan to start, talk with your healthcare provider before using this patch.
More Information About Neupro and BreastfeedingRotigotine (the active ingredient in Neupro) passes through breast milk in rats. However, no research has been done to see if it also passes through breast milk in humans.
Studies have shown that Neupro can lower prolactin levels in humans. Because prolactin is a hormone that is important for breastfeeding, Neupro could affect a woman's ability to breastfeed successfully.
Talking with Your Healthcare ProviderYou should discuss breastfeeding and Neupro use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.